Cargando…

Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes

OBJECTIVE: To explore the prevalence of lipid abnormalities and their relationship with albumin excretion and microalbuminuria in adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: The study population comprised 895 young subjects with type 1 diabetes (490 males); median age at the basel...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcovecchio, M. Loredana, Dalton, R. Neil, Prevost, A. Toby, Acerini, Carlo L., Barrett, Timothy G., Cooper, Jason D., Edge, Julie, Neil, Andrew, Shield, Julian, Widmer, Barry, Todd, John A., Dunger, David B.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660471/
https://www.ncbi.nlm.nih.gov/pubmed/19171721
http://dx.doi.org/10.2337/dc08-1641
_version_ 1782165739602444288
author Marcovecchio, M. Loredana
Dalton, R. Neil
Prevost, A. Toby
Acerini, Carlo L.
Barrett, Timothy G.
Cooper, Jason D.
Edge, Julie
Neil, Andrew
Shield, Julian
Widmer, Barry
Todd, John A.
Dunger, David B.
author_facet Marcovecchio, M. Loredana
Dalton, R. Neil
Prevost, A. Toby
Acerini, Carlo L.
Barrett, Timothy G.
Cooper, Jason D.
Edge, Julie
Neil, Andrew
Shield, Julian
Widmer, Barry
Todd, John A.
Dunger, David B.
author_sort Marcovecchio, M. Loredana
collection PubMed
description OBJECTIVE: To explore the prevalence of lipid abnormalities and their relationship with albumin excretion and microalbuminuria in adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: The study population comprised 895 young subjects with type 1 diabetes (490 males); median age at the baseline assessment was 14.5 years (range 10–21.1), and median diabetes duration was 4.8 years (0.2–17). A total of 2,194 nonfasting blood samples were collected longitudinally for determination of total cholesterol, LDL cholesterol, HDL cholesterol, TG, and non-HDL cholesterol. Additional annually collected data on anthropometric parameters, A1C, and albumin-to-creatinine ratio (ACR) were available. RESULTS: Total cholesterol, LDL cholesterol, HDL cholesterol, and non-HDL cholesterol were higher in females than in males (all P < 0.001). A significant proportion of subjects presented sustained lipid abnormalities during follow-up: total cholesterol >5.2 mmol/l (18.6%), non-HDL cholesterol >3.4 mmol/l (25.9%), TG >1.7 mmol/l (20.1%), and LDL cholesterol >3.4 mmol/l (9.6%). Age and duration were significantly related to all lipid parameters (P < 0.001); A1C was independently related to all parameters (P < 0.001) except HDL cholesterol, whereas BMI SD scores were related to all parameters (P < 0.05) except total cholesterol. Total cholesterol and non-HDL cholesterol were independently related to longitudinal changes in ACR (B coefficient ± SE): 0.03 ± 0.01/1 mmol/l, P = 0.009, and 0.32 ± 0.014/1 mmol/l, P = 0.02, respectively. Overall mean total cholesterol and non-HDL cholesterol were higher in microalbuminuria positive (n = 115) than in normoalbuminuric subjects (n = 780): total cholesterol 4.7 ± 1.2 vs. 4.5 ± 0.8 mmol/l (P = 0.04) and non-HDL cholesterol 3.2 ± 1.2 vs. 2.9 ± 0.8 mmol/l (P = 0.03). CONCLUSIONS: In this longitudinal study of adolescents with type 1 diabetes, sustained lipid abnormalities were related to age, duration, BMI, and A1C. Furthermore, ACR was related to both total cholesterol and non-HDL cholesterol, indicating a potential role in the pathogenesis of diabetic nephropathy.
format Text
id pubmed-2660471
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-26604712010-04-01 Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes Marcovecchio, M. Loredana Dalton, R. Neil Prevost, A. Toby Acerini, Carlo L. Barrett, Timothy G. Cooper, Jason D. Edge, Julie Neil, Andrew Shield, Julian Widmer, Barry Todd, John A. Dunger, David B. Diabetes Care Original Research OBJECTIVE: To explore the prevalence of lipid abnormalities and their relationship with albumin excretion and microalbuminuria in adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: The study population comprised 895 young subjects with type 1 diabetes (490 males); median age at the baseline assessment was 14.5 years (range 10–21.1), and median diabetes duration was 4.8 years (0.2–17). A total of 2,194 nonfasting blood samples were collected longitudinally for determination of total cholesterol, LDL cholesterol, HDL cholesterol, TG, and non-HDL cholesterol. Additional annually collected data on anthropometric parameters, A1C, and albumin-to-creatinine ratio (ACR) were available. RESULTS: Total cholesterol, LDL cholesterol, HDL cholesterol, and non-HDL cholesterol were higher in females than in males (all P < 0.001). A significant proportion of subjects presented sustained lipid abnormalities during follow-up: total cholesterol >5.2 mmol/l (18.6%), non-HDL cholesterol >3.4 mmol/l (25.9%), TG >1.7 mmol/l (20.1%), and LDL cholesterol >3.4 mmol/l (9.6%). Age and duration were significantly related to all lipid parameters (P < 0.001); A1C was independently related to all parameters (P < 0.001) except HDL cholesterol, whereas BMI SD scores were related to all parameters (P < 0.05) except total cholesterol. Total cholesterol and non-HDL cholesterol were independently related to longitudinal changes in ACR (B coefficient ± SE): 0.03 ± 0.01/1 mmol/l, P = 0.009, and 0.32 ± 0.014/1 mmol/l, P = 0.02, respectively. Overall mean total cholesterol and non-HDL cholesterol were higher in microalbuminuria positive (n = 115) than in normoalbuminuric subjects (n = 780): total cholesterol 4.7 ± 1.2 vs. 4.5 ± 0.8 mmol/l (P = 0.04) and non-HDL cholesterol 3.2 ± 1.2 vs. 2.9 ± 0.8 mmol/l (P = 0.03). CONCLUSIONS: In this longitudinal study of adolescents with type 1 diabetes, sustained lipid abnormalities were related to age, duration, BMI, and A1C. Furthermore, ACR was related to both total cholesterol and non-HDL cholesterol, indicating a potential role in the pathogenesis of diabetic nephropathy. American Diabetes Association 2009-04 2009-01-26 /pmc/articles/PMC2660471/ /pubmed/19171721 http://dx.doi.org/10.2337/dc08-1641 Text en © 2009 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details.
spellingShingle Original Research
Marcovecchio, M. Loredana
Dalton, R. Neil
Prevost, A. Toby
Acerini, Carlo L.
Barrett, Timothy G.
Cooper, Jason D.
Edge, Julie
Neil, Andrew
Shield, Julian
Widmer, Barry
Todd, John A.
Dunger, David B.
Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes
title Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes
title_full Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes
title_fullStr Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes
title_full_unstemmed Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes
title_short Prevalence of Abnormal Lipid Profiles and the Relationship With the Development of Microalbuminuria in Adolescents With Type 1 Diabetes
title_sort prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2660471/
https://www.ncbi.nlm.nih.gov/pubmed/19171721
http://dx.doi.org/10.2337/dc08-1641
work_keys_str_mv AT marcovecchiomloredana prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT daltonrneil prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT prevostatoby prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT acerinicarlol prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT barretttimothyg prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT cooperjasond prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT edgejulie prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT neilandrew prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT shieldjulian prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT widmerbarry prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT toddjohna prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes
AT dungerdavidb prevalenceofabnormallipidprofilesandtherelationshipwiththedevelopmentofmicroalbuminuriainadolescentswithtype1diabetes